<DOC>
	<DOCNO>NCT02580617</DOCNO>
	<brief_summary>This phase I study evaluate safety ALLO-ASC-CD treatment crohn ' disease . ALLO-ASC-CD intravenous infusion contain allogenic adipose-derived mesenchymal stem cell .</brief_summary>
	<brief_title>A Study Evaluate Safety ALLO-ASC-CD Treatment Crohn 's Disease</brief_title>
	<detailed_description>Adipose-derived stem cell direct injured tissue , reduce inflammation . Furthermore , immunomodulatory effect significant treat immune-related disease , crohn 's disease . Finally , ALLO-ASC-CD may provide new option treat crohn 's disease .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>1 . Subject 18 65 year age 2 . Subject diagnose Crohn 's disease endoscopic radiologic result 6 month 3 . Subject show intolerance failure conventional therapy ( steroid , immunosuppressive TNFalpha inhibitor ) 4 . Subject include CDAI 220450 screen period 5 . CRP &gt; 0.5mg/dL screening period 6 . Subject show affect site crohn 's disease either ileum large intestine , include 3 nonanastomotic ulcer result colonoscopy . 7 . Subjects satisfy clinical examination value screen period . A. Hemoglobin ≥ 8.0g/dL B. WBC ≥ 3,000/μL C. Lymphocyte ≥ 500/μL D.100,000/μL ≤ Platelet ≤ 1,200,000/μL E. AST ALT ≤ 3 x upper limit normal F. ALP ≤ 3 x upper limit normal G.Serum creatinine ≤ upper limit normal H.Serum albumin ≥ 2.0g/dL I.PT , aPTT≤ upper limit normal 8 . Negative urine betaHCG woman childbearing age . 9 . Subject able give write informed consent prior study start comply study requirement . 1 . Subject gastrointestinal tract A. Crohn 's disease invade proximal ileum . B . The evidence intra abdominal abscess screen period . C. The evidence abscess around anus screening period . D. Conditions subtotal colectomy total colectomy . E. Short bowel syndrome . F. Subject conduct elemental diet , tube feed parenteral nutrition within 3 week enrollment . G. Subject ileostomy colostomy . H Subject bowel stricture large intestine screening period . I . In case PI anticipate patient need get surgical intestinal tract surgery cause crohn 's disease . J . Subject adenoma large intestine K. Subject chronic inflammationassociated dysplasia . 2 . Subjects receive biological therapy within 60 day enrollment.. 3 . Subject infectious disease A . Acute chronic active HBV , HAV HIV B . Active tuberculosis . C. IGRA ( InterferonGamma Release Assay ) positive D. All kinds live vaccine inoculation except influenza vaccine within 4weeks registration E. Pneumonia , pyelonephritis Infection Clostridium within 4weeks screen visit . F.Subject history bacteremia serious bacterial fungal infection past 3 month . 4 . Subject malignant tumor cure yet 5 . Subject serious disease , opinion Investigator , would interfere evaluation study . 6 . Subject history blood clot pathological arterial thrombosis venous thrombosis 7 . Subject hypersensitive reaction bovinederived protein 8 . Subject surgery trauma within 6 week registration 9 . Subject pregnant breastfeeding . 10 . Subjects unwilling use `` effective '' method contraception study 11 . Subject experienced stem cell therapy 12 . Subject enrol another clinical study within 4weeks day screen 13 . Subject history alcohol drug abuse . 14 . Subject able understand objective study comply study requirement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>